Navigation Links
Regular prostate-specific antigen screening may be discontinued in certain elderly populations
Date:5/14/2008

ORLANDO, FL, May 21, 2008Men aged 75-80 with prostate-specific antigen (PSA) levels less than 3 ng/ml may be able to discontinue their regular prostate cancer screenings, according to new research presented today during the Annual Scientific Meeting of the American Urological Association (AUA). Johns Hopkins University researchers found that men in this age group who had a PSA level of 3 ng/ml or above had an increasing probability of death from prostate cancer in their remaining life, while men with lower PSA levels did not.

Researchers presented their findings to the media during a special press conference on May 21, 2008 at 11:00 a.m.

It is well known that prostate cancer screening is an important part of health maintenance and is very effective in detecting the disease at its most treatable stages in men who are regularly screened. However, prostate cancer can be slow growing and is not always aggressive enough to require immediate treatment. In older patients with shorter life expectancies, a non-aggressive, screen-detected cancer can result in increased stress and, possibly, unnecessary treatment. Researchers sought to determine a safe cut off for annual screening of older men based on PSA levels and an individuals probability of developing deadly prostate cancer in their remaining life.

Using a cohort of 849 participants in the Baltimore Longitudinal Study of Aging 122 with prostate cancer and 727 men without the disease Johns Hopkins researchers examined the proportion of men with aggressive prostate cancer by PSA and age to evaluate the safety of discontinuing PSA testing among older men. Study participants were aged 75-80 and were divided into two groups by PSA (3 ng/ml or above, and below 3 ng/ml).

Researchers compared multiple outcomes: probability of death from prostate cancer, death from prostate cancer, Gleason score 8 or above at diagnosis or PSA 20 ng/ml or above at diagnosis. Participants who presented with a PSA of at least 3 ng/ml had an increasing probability of death from prostate cancer, while men in the same age group with a PSA below 3 ng/ml did not share this risk. From these results, researchers conclude that it may be safe to discontinue regular testing in men ages 75-80 with PSA levels below 3 ng/ml as they are unlikely to develop aggressive disease during their remaining life.


'/>"/>

Contact: Lacey Holt
lholt@auanet.org
American Urological Association
Source:Eurekalert

Related medicine news :

1. Girls, young women can cut risk of early breast cancer through regular exercise
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. STERIS Corporation Declares Regular Quarterly Dividend
4. High Numbers of Children With Special Needs Have Health Insurance, Regular Caregivers, HRSA Survey Finds
5. Landauer, Inc. Declares Regular Cash Dividend
6. Cholesterol-Lowering Drugs May Ease Irregular Heartbeat
7. Northwestern Memorials Heart Center Pioneers Minimally Invasive Surgery That Corrects Irregular Heart Beat
8. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
9. Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend
10. Regular marijuana use increases risk of hepatitis C-related liver damage
11. A Little Regular Exercise Extends Mens Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017  PMD ... OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... strategic hub service that expedites and streamlines patient and ... Spiro PD 2.0, and wellness management services.  ... medical device used to measure lung function for a ...
Breaking Medicine Technology: